http://www.theramed.com Press Releases from Theramed en-us 1999-2011 Body1, Inc. All rights reserved. Thu, 07 Apr 2011 16:02:43 EST http://blogs.law.harvard.edu/tech/rss Body1 Rssmaker 1.0 Business Information editor@body1.com editor@body1.com 40 http://www.theramed.com/images/bodylogo1_tag.gif http://www.theramed.com http://www.theramed.com/news/prestigious.html Theramed Corporation (“Theramed”) is attending the upcoming J.P. Morgan Health Care Conference in San Francisco from January10th through the 13th. Anyone interested in learning more about Theramed or meeting together to discuss joint medical commercialization opportunities in the Canadian market, please contact Bill Baugh, CEO. Tue, 04 Jan 2011 00:00:00 EST http://www.theramed.com/news/prestigious.html Business, Medicine http://www.theramed.com/news/cardio.html Sunnybrook Hospital Department of Cardiovascular Surgery’s poster “ Mitigation of External Wound Infection by Application of a Gentamicin-Impregnated Sponge at the Time of Sternal Closure .“ has been accepted by the Canadian Cardiovascular Congress (CCC). This poster is now part of the CCC’s Scientific Program. Thu, 28 Oct 2010 00:00:00 EST http://www.theramed.com/news/cardio.html Business, Medicine http://www.theramed.com/news/bioeurope.html Theramed Corporation (“Theramed”) is attending the upcoming BIO-Europe conference November 15-17 in Munich, Germany. Fri, 08 Oct 2010 00:00:00 EST http://www.theramed.com/news/bioeurope.html Business, Medicine http://www.theramed.com/news/bourne01.html Bourne Partners is pleased to announce that Ms. Helen Stevenson, former Assistant Deputy Minister and Executive Officer, Ontario Public Drug Programs, has joined the firm as an Executive Advisor. In her five years in the Ontario Government, she led two sets of major reforms related to brand and generic drug pricing, and pharmacy reimbursement. Ms. Stevenson was also responsible for creating a new enterprise to manage all activities dealing with the publicly funded prescription drug programs, focused on reining in health care expenditures while at the same time providing access to new drugs for Ontarians. Fri, 10 Sep 2010 00:00:00 EST http://www.theramed.com/news/bourne01.html Business, Medicine http://www.theramed.com/news/TBEFActs_launch.html Theramed Corporation and Body1, Inc. announce the re-launch of a novel web site informing Canadians about Tick-Borne Encephalitis (TBE) at http://www.tbefacts.com. Theramed partnered with Body1 to enhance this unique online resource for overseas travelers. Tue, 10 Aug 2010 00:00:00 EST http://www.theramed.com/news/TBEFActs_launch.html Business, Medicine http://www.theramed.com/news/article06.htm Theramed Corporation announces an extension until March 31, 2018 of their exclusive right to import, market and distribute COLLATAMP® G in Canada. This was an extension of the original agreement assigned to Theramed in 2008 with EUSA Pharma Ltd. Tue, 15 Jun 2010 00:00:00 EST http://www.theramed.com/news/article06.htm Business, Medicine http://www.theramed.com/news/article04.html Theramed Corporation and Body1, Inc. announce the re-launch of Theramed’s corporate web site http://www.theramed.com. Theramed partnered with Body1 to enhance their corporate website by refreshing its design and adding new information and tools for Theramed’s stakeholders and website visitors. Fri, 12 Mar 2010 00:00:00 EST http://www.theramed.com/news/article04.html Business, Medicine http://www.theramed.com/news/article02.html Bourne Capital Partners, LLC (“Bourne Partners”) through its Canadian subsidiary, Critique Pharmaceuticals Inc., announces the acquisition of Theramed Corporation (“Theramed”). Theramed is a full-service Canadian medical device, pharmaceutical and biotech commercialization company with warehousing, distribution, regulatory, scientific affairs and sales and marketing capability. Founded in 1994 and headquartered in the Toronto suburb of Mississauga, Ontario, Theramed focuses on providing healthcare products used in Canadian hospitals and other critical care settings. Wed, 14 May 2008 00:00:00 EST http://www.theramed.com/news/article02.html Business, Medicine http://www.theramed.com/news/article01.html Building upon their January 2006 agreement with EMS Sigma Pharma for Canadian commercialization of EMS's organ transplantation portfolio, Theramed is pleased to announce the completion of their major shift in strategic direction which now sees the organization focusing entirely on Specialty Care products in the Critical Care / Hospital setting. Sun, 28 Jan 2007 00:00:00 EST http://www.theramed.com/news/article01.html Business, Medicine